FDA Clears UriSponge®: A Streamlined, Cost-Effective Solution for Urine Specimen Collection and Transport
Read MoreWASPLAB® AND PHENOMATRIX® AI ARE MAKING WAVES IN CANADA
Read MoreCopan Colibrí™ Receives Third FDA Clearance, Further Expanding Automated ID/AST Workup Capabilities
Read MoreCopan Unveils Website Redesign
Read MoreCopan Diagnostics Announces Leadership Change
Read MoreCopan Diagnostics is pleased to announce that its innovative urine collection and transport device, UriSponge®, has received clearance from the U.S. Food and Drug Administration (FDA).
December 9, 2024
Copan Colibrí™ Receives Third FDA Clearance, Further Expanding Automated ID/AST Workup Capabilities
January 30, 2024